Suppr超能文献

嵌合胸腺移植诱导免疫耐受

Induction of immunological tolerance by chimeric thymus transplantation.

作者信息

Palathumpat V, VandePutte M, Waer M

机构信息

Rega Institute for Medical Research, University of Leuven, Belgium.

出版信息

Thymus. 1989;13(1-2):113-22.

PMID:2533753
Abstract

The role of bone marrow derived cells (BMD) within the thymus during the induction of immunological tolerance was investigated using transplantation of chimeric thymuses. Chimeric thymuses were constructed by reconstituting lethally irradiated BALB/C recipients with T-cell depleted C3H bone marrow (BM) cells. Two to three months post bone marrow transplantation the thymuses of these animals, in which the epithelium was of BALB/C origin and BMD cells of C3H origin (verified by immunoperoxidase staining), were transplanted into thymectomized, lethally irradiated BALB/C recipients which were reconstituted with T-cell depleted syngeneic (BALB/C) bone marrow cells. Induction of specific tolerance to the BMD cells (C3H origin) present in the chimeric thymus could be demonstrated in MLR at 3 to 6 months post chimeric thymus transplantation. It is concluded that bone marrow derived cells are able to induce immunological tolerance within the thymus.

摘要

利用嵌合胸腺移植,研究了骨髓来源细胞(BMD)在胸腺内诱导免疫耐受过程中的作用。通过用T细胞去除的C3H骨髓(BM)细胞重建经致死剂量照射的BALB/C受体,构建嵌合胸腺。骨髓移植后两到三个月,将这些动物的胸腺移植到经胸腺切除、接受致死剂量照射且用T细胞去除的同基因(BALB/C)骨髓细胞重建的BALB/C受体中,这些动物胸腺的上皮细胞来源于BALB/C,BMD细胞来源于C3H(通过免疫过氧化物酶染色验证)。在嵌合胸腺移植后3至6个月的混合淋巴细胞反应(MLR)中,可以证明对嵌合胸腺中存在的BMD细胞(C3H来源)诱导了特异性耐受。结论是骨髓来源细胞能够在胸腺内诱导免疫耐受。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验